|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
New York Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New YorkLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Royalty Pharma
| | | Phone: | (212) 883-0200 | Fax: | (212) 883-2260 | Year Established: | 1996 | Main Contact: | Pablo Legoretta, Founder & CEO | | Other Contacts: | George Lloyd, Executive & General Counsel Douglas Erb, Chief Administrative Officer & Chief Compliance Officer Jim Reddoch, Ph.D., Executive VP, Head of Research & Investments Susannah Gray, Executive VP & CFO
| | Company Description | Royalty Pharma is the industry leader in acquiring royalty interests in marketed and late stage biopharmaceutical products, with total assets of over $15 billion. Royalty Pharma owns royalty interests in 40 products ncluding Humira, Remicade, Lyrica, Prezista, Truvada, Januvia, Tecfidera, Imbruvica, Kalydeco and Orkambi. Royalty Pharma also funds late - stage clinical trials in exchange for royalty interests. | |
|
|
|
|
|